BioCentury
ARTICLE | Company News

Daiichi Sankyo, Eli Lilly sales and marketing update

April 13, 2009 7:00 AM UTC

The partners launched Efient (Effient-U.S.) prasugrel in the U.K., where they will co-promote it to prevent atherothrombotic cardiovascular events in patients undergoing percutaneous coronary interve...